Satya Prakash Yadav/X
Aug 15, 2026, 16:00
Satya Prakash Yadav: Overcoming Overtreatment in Pediatric Immune Thrombocytopenia
Satya Prakash Yadav, Director of Pediatric Hemato-Oncology and Bone Marrow Transplant at Medanta, shared Blood Journals Portfolio’s post on X, adding։
“Immune thrombocytopenia (ITP) in children is most over treated disorder.
No treatment still remains best treatment for most patients!
Don’t be scared of low platelets – These platelets are fresh platelets, large in size and functionally more powerful then older platelets.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments
-
Nov 16, 2026, 12:44Stefan Prendić: How Intronic Variants Affect Rh Blood Group Antigen Expression
-
Nov 16, 2026, 12:26Samwel Mikaye: Understanding Warfarin and Its Clinical Management
-
Nov 16, 2026, 12:14Sophia Delicou: Ensuring Lifelong Health Beyond Stem Cell Transplantation
-
Nov 16, 2026, 12:06Edward Lee Carter: Has PEPPER Changed the Role of Aspirin in Arthroplasty VTE Prophylaxis?
-
Nov 16, 2026, 11:53Eduardo Ortiz Bello: The Endothelium in Hemostasis and Microcirculation
-
Nov 16, 2026, 11:51Phil Spinella: Advancing Transfusion Medicine Through Collaboration
-
Nov 16, 2026, 11:46Madiha Chowdhury: Behind the Scenes of Blood Transfusion Services
-
Nov 16, 2026, 11:43Nasir Al Allawi: Honouring Excellence in Haematopathology